Hosted on MSN28d
Merck Licenses a Weight-Loss Pill. It’s Bad News for Obesity Biotechs.
Merck said Wednesday it had licensed an experimental GLP-1 obesity pill from a Chinese drugmaker ... and Novo Nordisk’s dominance in the weight-loss market. It also comes amid worries that ...
Hosted on MSN1mon
Merck’s weight-loss pill deal: what it means for Eli Lilly
The said agreement wins it rights to HS-10535 – an experimental weight-loss pill (oral) developed by the Chinese drugmaker. Hansoh will receive an upfront payment of $112 million from Merck and ...
MarketWatch1mon
Merck, Hansoh Pharma in Obesity Pill License Potentially Worth More Than $2 Billion
Merck & Co. is licensing a potential oral obesity drug from Hansoh Pharma in a deal potentially worth more than $2 billion to the Chinese biopharmaceutical company. Merck on Wednesday said it will ...